Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment Tapering in JIA With Inactive Disease on Biologic Therapy
NCT02840175Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2017
- Primary completion
- Oct 2019
- Modality
- Antibody Conjugates, Engineered Antibody Formats, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of etanercept, adalimumab, abatacept, tocilizumab in juvenile idiopathic arthritis (JIA), sponsored by Assistance publique - Hôpitaux de Paris. Started May 2017; status: completed.
02
Drugs
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NCT02840175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02840175.